Sleep Disturbances in the 2nd and 3rd Trimester
Sleep Patterns and Disturbances in the Second and Third Trimester of Uncomplicated Pregnancy
Sleep disorders and disturbances are mostly underestimated in clinical practice. Moreover, this problem is generally neglected by the pregnant themselves. Today, it is important to underline any problem that may have an affect to improve the quality of life during pregnancy.
This study assesses the sleep quality, insomnia patterns and obstructive sleep apnea in the second and third trimesters of pregnancy.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Women with uncomplicated pregnancy in the second or third trimester who apply for the routine check will be included.
Specific questionnaires will be used to measure the sleep disorders in addition to the socio-demographic measures:
Pittsburgh Sleep Quality Index, Insomnia Severity Index, Berlin Questionnaire and Stop-Bang Questionnaire.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Bartin, Tyrkia
- Bartin State Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- 2nd or 3rd trimester of pregnancy
Exclusion Criteria:
- Complicated pregnancy
- Multiple pregnancy
- Known sleep disorder
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: Bare etui
- Tidsperspektiver: Tverrsnitt
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Participants
Pregnant women in the 2nd or 3th trimester Patient-reported scales to measure sleep disorders
|
Patient-reported scales to measure sleep disorders include below mentioned scales: Pittsburgh Sleep Quality Index; measures the quality of sleep Berlin Questionnaire; measures the obstructive sleep apnea Stop-Bang questionnaire; measures the obstructive sleep apnea Insomnia Severity Index; measures the insomnia and related parameters |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Pittsburgh Sleep Quality Index (PSQI)
Tidsramme: Through study completion, an average of 39 weeks
|
The order of the PSQI items has been modified from the original order in order to fit the first 9 items (which are the only items that contribute to the total score) on a single page.
Item 10, which is the second page of the scale, does not contribute to the PSQI score.
In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty).
The component scores are summed to produce a global score (range 0 to 21).
Higher scores indicate worse sleep quality.
|
Through study completion, an average of 39 weeks
|
|
Berlin Questionnaire
Tidsramme: Through study completion, an average of 39 weeks
|
The questionnaire consists of 3 categories related to the risk of having sleep apnea.
Patients can be classified into High Risk or Low Risk based on their responses to the individual items and their overall scores in the symptom categories.
High Risk: if there are 2 or more categories where the score is positive.
Low Risk: if there is only 1 or no categories where the score is positive.
|
Through study completion, an average of 39 weeks
|
|
Stop-Bang questionnaire
Tidsramme: Through study completion, an average of 39 weeks
|
This questionnaire evaluates the risk of sleep apnea.
Low risk of OSA: Yes to 0-2 questions Intermediate risk of OSA: Yes to 3-4 questions High risk of OSA: Yes to 5-8 questions or Yes to 2 or more of 4 STOP questions + male gender or Yes to 2 or more of 4 STOP questions + BMI > 35 kg/m2 or Yes to 2 or more of 4 STOP questions + neck circumference.
|
Through study completion, an average of 39 weeks
|
|
Insomnia Severity Index (ISI)
Tidsramme: Through study completion, an average of 39 weeks
|
ISI measures the insomnia and related parameters.
Scoring and Interpretation as follows: Add the scores for all seven items (questions 1 + 2 + 3 + 4 + 5 +6 + 7) will give the total score.
Total score categories: 0-7 = No clinically significant insomnia 8-14 = Subthreshold insomnia 15-21 = Clinical insomnia (moderate severity) 22-28 = Clinical insomnia (severe)
|
Through study completion, an average of 39 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Psykiske lidelser
- Patologiske prosesser
- Sykdommer i nervesystemet
- Sykdommer i luftveiene
- Respirasjonsforstyrrelser
- Søvnforstyrrelser, iboende
- Nevrologiske manifestasjoner
- Tegn og symptomer, luftveier
- Søvnapné syndromer
- Søvnapné, obstruktiv
- Sykdom
- Søvnvåkenforstyrrelser
- Søvninitiering og vedlikeholdsforstyrrelser
- Apné
- Dyssomnier
- Parasomnier
Andre studie-ID-numre
- 2018-1
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .